The Patent Finder

MS Therapeutics Limited

Also on record
Records under this name other than patents MS Therapeutics Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to MS Therapeutics Limited

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,197,794Core 2GLCNAC-T Inhibitors
Lapsed on the fee record
Ended Jun 12, 2020 · Medium confidence
Lapsed on the fee recordEnded Jun 12, 2020Medium confidence
US 7,998,943Core 2 Glcnac-T Inhibitors III
Lapsed on the fee record
Ended Aug 16, 2019 · Medium confidence
Lapsed on the fee recordEnded Aug 16, 2019Medium confidence
US 7,906,493Core 2 Glcnac-T Inhibitors
Lapsed on the fee record
Ended Mar 15, 2019 · High confidence
Lapsed on the fee recordEnded Mar 15, 2019High confidence
US 7,811,781Core 2 BETA(1,6)-ACETYLGLYCOSAMINYLTRANSFERASE as Diagnostic Marker for Atherosclerosis
Lapsed on the fee record
Ended Oct 12, 2018 · High confidence
Lapsed on the fee recordEnded Oct 12, 2018High confidence
US 8,609,633Core 2 Glcnac-T Inhibitors
Lapsed on the fee record
Ended Dec 17, 2017 · Low confidence
Lapsed on the fee recordEnded Dec 17, 2017Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited